167 related articles for article (PubMed ID: 16260131)
1. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
[TBL] [Abstract][Full Text] [Related]
2. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.
Chan L; Das SK; Reddy TJ; Poisson C; Proulx M; Pereira O; Courchesne M; Roy C; Wang W; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Labrecque D; Bethell R; Hamel M; Courtemanche-Asselin P; L'Heureux L; David M; Nicolas O; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):793-6. PubMed ID: 14741291
[TBL] [Abstract][Full Text] [Related]
3. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
[TBL] [Abstract][Full Text] [Related]
4. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.
Chan L; Pereira O; Reddy TJ; Das SK; Poisson C; Courchesne M; Proulx M; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Roy C; Nasturica D; Moinet C; Bethell R; Hamel M; L'Heureux L; David M; Nicolas O; Courtemanche-Asselin P; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):797-800. PubMed ID: 14741292
[TBL] [Abstract][Full Text] [Related]
5. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.
Vandyck K; Cummings MD; Nyanguile O; Boutton CW; Vendeville S; McGowan D; Devogelaere B; Amssoms K; Last S; Rombauts K; Tahri A; Lory P; Hu L; Beauchamp DA; Simmen K; Raboisson P
J Med Chem; 2009 Jul; 52(14):4099-102. PubMed ID: 19507864
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation.
Ryu K; Kim ND; Choi SI; Han CK; Yoon JH; No KT; Kim KH; Seong BL
Bioorg Med Chem; 2009 Apr; 17(8):2975-82. PubMed ID: 19332375
[TBL] [Abstract][Full Text] [Related]
9. Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity.
Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Hofmann GA; Slater MJ; Haigh D; Dhanak D; Johnson VK; Parry NR; Thommes P
Bioorg Med Chem Lett; 2007 Apr; 17(7):1930-3. PubMed ID: 17270443
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
[TBL] [Abstract][Full Text] [Related]
11. Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.
Chan L; Reddy TJ; Proulx M; Das SK; Pereira O; Wang W; Siddiqui A; Yannopoulos CG; Poisson C; Turcotte N; Drouin A; Alaoui-Ismaili MH; Bethell R; Hamel M; L'Heureux L; Bilimoria D; Nguyen-Ba N
J Med Chem; 2003 Apr; 46(8):1283-5. PubMed ID: 12672227
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors.
Biswal BK; Cherney MM; Wang M; Chan L; Yannopoulos CG; Bilimoria D; Nicolas O; Bedard J; James MN
J Biol Chem; 2005 May; 280(18):18202-10. PubMed ID: 15746101
[TBL] [Abstract][Full Text] [Related]
13. Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid.
Stansfield I; Avolio S; Colarusso S; Gennari N; Narjes F; Pacini B; Ponzi S; Harper S
Bioorg Med Chem Lett; 2004 Oct; 14(20):5085-8. PubMed ID: 15380204
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors.
Nichols DB; Leão RA; Basu A; Chudayeu M; de Moraes Pde F; Talele TT; Costa PR; Kaushik-Basu N
Chem Biol Drug Des; 2013 May; 81(5):607-14. PubMed ID: 23311976
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of de novo evolution of hepatitis C virus NS5B polymerase inhibitors.
Chen PY; Hsu WT; Jhuo MD; Ou CY; Cheng TH; Shih TC; Wu CH; Wu RS; Hsia TC; Chung JG
In Vivo; 2011; 25(2):219-28. PubMed ID: 21471538
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides.
Cheng CC; Shipps GW; Yang Z; Kawahata N; Lesburg CA; Duca JS; Bandouveres J; Bracken JD; Jiang CK; Agrawal S; Ferrari E; Huang HC
Bioorg Med Chem Lett; 2010 Apr; 20(7):2119-24. PubMed ID: 20219368
[TBL] [Abstract][Full Text] [Related]
17. Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.
Yang H; Hendricks RT; Arora N; Nitzan D; Yee C; Lucas MC; Yang Y; Fung A; Rajyaguru S; Harris SF; Leveque VJ; Hang JQ; Pogam SL; Reuter D; Tavares GA
Bioorg Med Chem Lett; 2010 Aug; 20(15):4614-9. PubMed ID: 20584604
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase.
Reich S; Golbik RP; Geissler R; Lilie H; Behrens SE
J Biol Chem; 2010 Apr; 285(18):13685-93. PubMed ID: 20194503
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors.
Rong F; Chow S; Yan S; Larson G; Hong Z; Wu J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1663-6. PubMed ID: 17258458
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
